
Drug Screening Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
Description
Drug Screening Market Summary
Introduction and Market Overview
Drug screening involves testing biological samples to detect substances like illicit drugs, alcohol, and prescription medications, used in workplaces, healthcare, and law enforcement. The market is driven by rising global drug abuse, with 296 million people using drugs in 2021, and alcohol-related deaths accounting for 5.3% of global mortality. Chronic disease management and prescription drug abuse, particularly opioids, further fuel demand. Non-invasive methods like saliva and hair testing gain traction for their convenience. The global drug screening market is estimated at USD 5.0-9.0 billion in 2025, with a CAGR of 3.5%-7.3% through 2030.
Regional Market Trends
North America: The U.S. leads due to workplace regulations and opioid crisis response, with Canada focusing on alcohol testing.
Europe: Germany, France, and the UK drive growth with strict drug laws, emphasizing roadside testing.
Asia Pacific: China and India see rising demand due to workplace safety initiatives, with Japan prioritizing sports doping tests.
Rest of the World: Brazil expands screening in transportation, and the Middle East focuses on law enforcement applications.
Application Analysis
Hospitals: Expected growth of 3.7%-7.5%, driven by patient monitoring. Trends focus on opioid abuse detection.
Criminal Justice & Law Enforcement: Projected growth of 3.6%-7.4%, linked to drug trafficking control. Advances emphasize rapid roadside testing.
Workplaces: Anticipated growth of 3.8%-7.6%, tied to safety regulations. Developments prioritize non-invasive methods.
Others: Expected growth of 3.4%-7.2%, covering schools and individual users. Trends highlight home testing kits.
Type Analysis
Instruments: Expected growth of 3.8%-7.6%, valued for lab precision. Trends focus on AI-driven analysis.
Rapid Testing Devices: Projected growth of 3.9%-7.7%, linked to on-site needs. Advances emphasize saliva-based kits.
Consumables: Anticipated growth of 3.5%-7.3%, supporting testing volume. Trends highlight cost-effective reagents.
Services & Others: Expected growth of 3.4%-7.2%, covering lab outsourcing. Trends focus on digital reporting.
Key Market Players
Abbott: Offers rapid testing devices for workplaces.
Thermo Fisher Scientific: Provides advanced screening instruments.
OraSure Technologies: Specializes in saliva-based tests.
Drägerwerk: Focuses on breathalyzers for alcohol detection.
Quest Diagnostics: Emphasizes lab-based screening services.
Porter’s Five Forces Analysis
Threat of New Entrants: Moderate, due to regulatory barriers, but low-cost rapid tests lower entry hurdles.
Threat of Substitutes: Low, as alternative methods lack screening accuracy, though self-reporting persists.
Bargaining Power of Buyers: Moderate, with employers seeking affordable tests, but regulatory standards limit options.
Bargaining Power of Suppliers: Low, with multiple reagent and device providers.
Competitive Rivalry: High, with players competing on test sensitivity and speed.
Market Opportunities and Challenges
Opportunities:
Addressing drug abuse, affecting 296 million people globally.
Tackling alcohol-related deaths, causing 3 million annually.
Managing prescription drug abuse, linked to 500,000 deaths yearly.
Leveraging non-invasive testing for wider adoption.
Aligning with WHO’s safety initiatives for workplace screening.
Supporting regulatory mandates in transportation and sports.
Challenges:
High costs of advanced instruments.
Regulatory delays, with FDA approvals taking 1-2 years.
Privacy concerns in workplace testing.
False positives affecting test reliability.
Limited awareness in developing regions.
Introduction and Market Overview
Drug screening involves testing biological samples to detect substances like illicit drugs, alcohol, and prescription medications, used in workplaces, healthcare, and law enforcement. The market is driven by rising global drug abuse, with 296 million people using drugs in 2021, and alcohol-related deaths accounting for 5.3% of global mortality. Chronic disease management and prescription drug abuse, particularly opioids, further fuel demand. Non-invasive methods like saliva and hair testing gain traction for their convenience. The global drug screening market is estimated at USD 5.0-9.0 billion in 2025, with a CAGR of 3.5%-7.3% through 2030.
Regional Market Trends
North America: The U.S. leads due to workplace regulations and opioid crisis response, with Canada focusing on alcohol testing.
Europe: Germany, France, and the UK drive growth with strict drug laws, emphasizing roadside testing.
Asia Pacific: China and India see rising demand due to workplace safety initiatives, with Japan prioritizing sports doping tests.
Rest of the World: Brazil expands screening in transportation, and the Middle East focuses on law enforcement applications.
Application Analysis
Hospitals: Expected growth of 3.7%-7.5%, driven by patient monitoring. Trends focus on opioid abuse detection.
Criminal Justice & Law Enforcement: Projected growth of 3.6%-7.4%, linked to drug trafficking control. Advances emphasize rapid roadside testing.
Workplaces: Anticipated growth of 3.8%-7.6%, tied to safety regulations. Developments prioritize non-invasive methods.
Others: Expected growth of 3.4%-7.2%, covering schools and individual users. Trends highlight home testing kits.
Type Analysis
Instruments: Expected growth of 3.8%-7.6%, valued for lab precision. Trends focus on AI-driven analysis.
Rapid Testing Devices: Projected growth of 3.9%-7.7%, linked to on-site needs. Advances emphasize saliva-based kits.
Consumables: Anticipated growth of 3.5%-7.3%, supporting testing volume. Trends highlight cost-effective reagents.
Services & Others: Expected growth of 3.4%-7.2%, covering lab outsourcing. Trends focus on digital reporting.
Key Market Players
Abbott: Offers rapid testing devices for workplaces.
Thermo Fisher Scientific: Provides advanced screening instruments.
OraSure Technologies: Specializes in saliva-based tests.
Drägerwerk: Focuses on breathalyzers for alcohol detection.
Quest Diagnostics: Emphasizes lab-based screening services.
Porter’s Five Forces Analysis
Threat of New Entrants: Moderate, due to regulatory barriers, but low-cost rapid tests lower entry hurdles.
Threat of Substitutes: Low, as alternative methods lack screening accuracy, though self-reporting persists.
Bargaining Power of Buyers: Moderate, with employers seeking affordable tests, but regulatory standards limit options.
Bargaining Power of Suppliers: Low, with multiple reagent and device providers.
Competitive Rivalry: High, with players competing on test sensitivity and speed.
Market Opportunities and Challenges
Opportunities:
Addressing drug abuse, affecting 296 million people globally.
Tackling alcohol-related deaths, causing 3 million annually.
Managing prescription drug abuse, linked to 500,000 deaths yearly.
Leveraging non-invasive testing for wider adoption.
Aligning with WHO’s safety initiatives for workplace screening.
Supporting regulatory mandates in transportation and sports.
Challenges:
High costs of advanced instruments.
Regulatory delays, with FDA approvals taking 1-2 years.
Privacy concerns in workplace testing.
False positives affecting test reliability.
Limited awareness in developing regions.
Table of Contents
104 Pages
- Chapter 1 Executive Summary
- Chapter 2 Abbreviation and Acronyms
- Chapter 3 Preface
- 3.1 Research Scope
- 3.2 Research Sources
- 3.2.1 Data Sources
- 3.2.2 Assumptions
- 3.3 Research Method
- Chapter Four Market Landscape
- 4.1 Market Overview
- 4.2 Classification/Types
- 4.3 Application/End Users
- Chapter 5 Market Trend Analysis
- 5.1 Introduction
- 5.2 Drivers
- 5.3 Restraints
- 5.4 Opportunities
- 5.5 Threats
- Chapter 6 Industry Chain Analysis
- 6.1 Upstream/Suppliers Analysis
- 6.2 Drug Screening Analysis
- 6.2.1 Technology Analysis
- 6.2.2 Cost Analysis
- 6.2.3 Market Channel Analysis
- 6.3 Downstream Buyers/End Users
- Chapter 7 Latest Market Dynamics
- 7.1 Latest News
- 7.2 Merger and Acquisition
- 7.3 Planned/Future Project
- 7.4 Policy Dynamics
- Chapter 8 Historical and Forecast Drug Screening Market in North America (2020-2030)
- 8.1 Drug Screening Market Size
- 8.2 Drug Screening Market by End Use
- 8.3 Competition by Players/Suppliers
- 8.4 Drug Screening Market Size by Type
- 8.5 Key Countries Analysis
- 8.5.1 United States
- 8.5.2 Canada
- 8.5.3 Mexico
- Chapter 9 Historical and Forecast Drug Screening Market in South America (2020-2030)
- 9.1 Drug Screening Market Size
- 9.2 Drug Screening Market by End Use
- 9.3 Competition by Players/Suppliers
- 9.4 Drug Screening Market Size by Type
- 9.5 Key Countries Analysis
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Chile
- 9.5.4 Peru
- Chapter 10 Historical and Forecast Drug Screening Market in Asia & Pacific (2020-2030)
- 10.1 Drug Screening Market Size
- 10.2 Drug Screening Market by End Use
- 10.3 Competition by Players/Suppliers
- 10.4 Drug Screening Market Size by Type
- 10.5 Key Countries Analysis
- 10.5.1 China
- 10.5.2 India
- 10.5.3 Japan
- 10.5.4 South Korea
- 10.5.5 Southest Asia
- 10.5.6 Australia
- Chapter 11 Historical and Forecast Drug Screening Market in Europe (2020-2030)
- 11.1 Drug Screening Market Size
- 11.2 Drug Screening Market by End Use
- 11.3 Competition by Players/Suppliers
- 11.4 Drug Screening Market Size by Type
- 11.5 Key Countries Analysis
- 11.5.1 Germany
- 11.5.2 France
- 11.5.3 United Kingdom
- 11.5.4 Italy
- 11.5.5 Spain
- 11.5.6 Belgium
- 11.5.7 Netherlands
- 11.5.8 Austria
- 11.5.9 Poland
- 11.5.10 Russia
- Chapter 12 Historical and Forecast Drug Screening Market in MEA (2020-2030)
- 12.1 Drug Screening Market Size
- 12.2 Drug Screening Market by End Use
- 12.3 Competition by Players/Suppliers
- 12.4 Drug Screening Market Size by Type
- 12.5 Key Countries Analysis
- 12.5.1 Egypt
- 12.5.2 Israel
- 12.5.3 South Africa
- 12.5.4 Gulf Cooperation Council Countries
- 12.5.5 Turkey
- Chapter 13 Summary For Global Drug Screening Market (2020-2025)
- 13.1 Drug Screening Market Size
- 13.2 Drug Screening Market by End Use
- 13.3 Competition by Players/Suppliers
- 13.4 Drug Screening Market Size by Type
- Chapter 14 Global Drug Screening Market Forecast (2025-2030)
- 14.1 Drug Screening Market Size Forecast
- 14.2 Drug Screening Application Forecast
- 14.3 Competition by Players/Suppliers
- 14.4 Drug Screening Type Forecast
- Chapter 15 Analysis of Global Key Vendors
- 15.1 Abbott
- 15.1.1 Company Profile
- 15.1.2 Main Business and Drug Screening Information
- 15.1.3 SWOT Analysis of Abbott
- 15.1.4 Abbott Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- 15.2 Thermo Fisher Scientific
- 15.2.1 Company Profile
- 15.2.2 Main Business and Drug Screening Information
- 15.2.3 SWOT Analysis of Thermo Fisher Scientific
- 15.2.4 Thermo Fisher Scientific Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- 15.3 OraSure Technologies
- 15.3.1 Company Profile
- 15.3.2 Main Business and Drug Screening Information
- 15.3.3 SWOT Analysis of OraSure Technologies
- 15.3.4 OraSure Technologies Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- 15.4 Drägerwerk AG & Co. KGaA
- 15.4.1 Company Profile
- 15.4.2 Main Business and Drug Screening Information
- 15.4.3 SWOT Analysis of Drägerwerk AG & Co. KGaA
- 15.4.4 Drägerwerk AG & Co. KGaA Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- 15.5 Quest Diagnostics Incorporated
- 15.5.1 Company Profile
- 15.5.2 Main Business and Drug Screening Information
- 15.5.3 SWOT Analysis of Quest Diagnostics Incorporated
- 15.5.4 Quest Diagnostics Incorporated Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- 15.6 Labcorp
- 15.6.1 Company Profile
- 15.6.2 Main Business and Drug Screening Information
- 15.6.3 SWOT Analysis of Labcorp
- 15.6.4 Labcorp Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- 15.7 Roche
- 15.7.1 Company Profile
- 15.7.2 Main Business and Drug Screening Information
- 15.7.3 SWOT Analysis of Roche
- 15.7.4 Roche Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- 15.8 Siemens Healthcare
- 15.8.1 Company Profile
- 15.8.2 Main Business and Drug Screening Information
- 15.8.3 SWOT Analysis of Siemens Healthcare
- 15.8.4 Siemens Healthcare Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- 15.9 Alfa Scientific Designs
- 15.9.1 Company Profile
- 15.9.2 Main Business and Drug Screening Information
- 15.9.3 SWOT Analysis of Alfa Scientific Designs
- 15.9.4 Alfa Scientific Designs Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- 15.10 Omega Laboratories
- 15.10.1 Company Profile
- 15.10.2 Main Business and Drug Screening Information
- 15.10.3 SWOT Analysis of Omega Laboratories
- 15.10.4 Omega Laboratories Drug Screening Revenue, Gross Margin and Market Share (2020-2025)
- Please ask for sample pages for full companies list
- Tables and Figures
- Table Abbreviation and Acronyms
- Table Research Scope of Drug Screening Report
- Table Data Sources of Drug Screening Report
- Table Major Assumptions of Drug Screening Report
- Figure Market Size Estimated Method
- Figure Major Forecasting Factors
- Figure Drug Screening Picture
- Table Drug Screening Classification
- Table Drug Screening Applications
- Table Drivers of Drug Screening Market
- Table Restraints of Drug Screening Market
- Table Opportunities of Drug Screening Market
- Table Threats of Drug Screening Market
- Table Covid-19 Impact For Drug Screening Market
- Table Raw Materials Suppliers
- Table Different Production Methods of Drug Screening
- Table Cost Structure Analysis of Drug Screening
- Table Key End Users
- Table Latest News of Drug Screening Market
- Table Merger and Acquisition
- Table Planned/Future Project of Drug Screening Market
- Table Policy of Drug Screening Market
- Table 2020-2030 North America Drug Screening Market Size
- Figure 2020-2030 North America Drug Screening Market Size and CAGR
- Table 2020-2030 North America Drug Screening Market Size by Application
- Table 2020-2025 North America Drug Screening Key Players Revenue
- Table 2020-2025 North America Drug Screening Key Players Market Share
- Table 2020-2030 North America Drug Screening Market Size by Type
- Table 2020-2030 United States Drug Screening Market Size
- Table 2020-2030 Canada Drug Screening Market Size
- Table 2020-2030 Mexico Drug Screening Market Size
- Table 2020-2030 South America Drug Screening Market Size
- Figure 2020-2030 South America Drug Screening Market Size and CAGR
- Table 2020-2030 South America Drug Screening Market Size by Application
- Table 2020-2025 South America Drug Screening Key Players Revenue
- Table 2020-2025 South America Drug Screening Key Players Market Share
- Table 2020-2030 South America Drug Screening Market Size by Type
- Table 2020-2030 Brazil Drug Screening Market Size
- Table 2020-2030 Argentina Drug Screening Market Size
- Table 2020-2030 Chile Drug Screening Market Size
- Table 2020-2030 Peru Drug Screening Market Size
- Table 2020-2030 Asia & Pacific Drug Screening Market Size
- Figure 2020-2030 Asia & Pacific Drug Screening Market Size and CAGR
- Table 2020-2030 Asia & Pacific Drug Screening Market Size by Application
- Table 2020-2025 Asia & Pacific Drug Screening Key Players Revenue
- Table 2020-2025 Asia & Pacific Drug Screening Key Players Market Share
- Table 2020-2030 Asia & Pacific Drug Screening Market Size by Type
- Table 2020-2030 China Drug Screening Market Size
- Table 2020-2030 India Drug Screening Market Size
- Table 2020-2030 Japan Drug Screening Market Size
- Table 2020-2030 South Korea Drug Screening Market Size
- Table 2020-2030 Southeast Asia Drug Screening Market Size
- Table 2020-2030 Australia Drug Screening Market Size
- Table 2020-2030 Europe Drug Screening Market Size
- Figure 2020-2030 Europe Drug Screening Market Size and CAGR
- Table 2020-2030 Europe Drug Screening Market Size by Application
- Table 2020-2025 Europe Drug Screening Key Players Revenue
- Table 2020-2025 Europe Drug Screening Key Players Market Share
- Table 2020-2030 Europe Drug Screening Market Size by Type
- Table 2020-2030 Germany Drug Screening Market Size
- Table 2020-2030 France Drug Screening Market Size
- Table 2020-2030 United Kingdom Drug Screening Market Size
- Table 2020-2030 Italy Drug Screening Market Size
- Table 2020-2030 Spain Drug Screening Market Size
- Table 2020-2030 Belgium Drug Screening Market Size
- Table 2020-2030 Netherlands Drug Screening Market Size
- Table 2020-2030 Austria Drug Screening Market Size
- Table 2020-2030 Poland Drug Screening Market Size
- Table 2020-2030 Russia Drug Screening Market Size
- Table 2020-2030 MEA Drug Screening Market Size
- Figure 2020-2030 MEA Drug Screening Market Size and CAGR
- Table 2020-2030 MEA Drug Screening Market Size by Application
- Table 2020-2025 MEA Drug Screening Key Players Revenue
- Table 2020-2025 MEA Drug Screening Key Players Market Share
- Table 2020-2030 MEA Drug Screening Market Size by Type
- Table 2020-2030 Egypt Drug Screening Market Size
- Table 2020-2030 Israel Drug Screening Market Size
- Table 2020-2030 South Africa Drug Screening Market Size
- Table 2020-2030 Gulf Cooperation Council Countries Drug Screening Market Size
- Table 2020-2030 Turkey Drug Screening Market Size
- Table 2020-2025 Global Drug Screening Market Size by Region
- Table 2020-2025 Global Drug Screening Market Size Share by Region
- Table 2020-2025 Global Drug Screening Market Size by Application
- Table 2020-2025 Global Drug Screening Market Share by Application
- Table 2020-2025 Global Drug Screening Key Vendors Revenue
- Figure 2020-2025 Global Drug Screening Market Size and Growth Rate
- Table 2020-2025 Global Drug Screening Key Vendors Market Share
- Table 2020-2025 Global Drug Screening Market Size by Type
- Table 2020-2025 Global Drug Screening Market Share by Type
- Table 2025-2030 Global Drug Screening Market Size by Region
- Table 2025-2030 Global Drug Screening Market Size Share by Region
- Table 2025-2030 Global Drug Screening Market Size by Application
- Table 2025-2030 Global Drug Screening Market Share by Application
- Table 2025-2030 Global Drug Screening Key Vendors Revenue
- Figure 2025-2030 Global Drug Screening Market Size and Growth Rate
- Table 2025-2030 Global Drug Screening Key Vendors Market Share
- Table 2025-2030 Global Drug Screening Market Size by Type
- Table 2025-2030 Drug Screening Global Market Share by Type
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.